31251-41-9

基本信息
8-氯-5,6-二氫-11H-苯并[5,6]環(huán)庚基[1,2-B]吡啶-11-酮
8-CHLORO-5,6-DIHYDRO-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDIN-11-ONE
8-CHLORO-10,11-DIHYDRO-4-AZA-5H-BENZO[A,D] CYCLOHEPTAN-5-ONE
8-CHLORO-5,6-DIHYDRO-11H-BENZO-(5,6)-CYCLOHEPTA-(1,2-B)-PYRIMIDINE-11-ON
8-Chloro-10,11-dihydro-4-aza-5
8-chloro-10,11-dihydro-4-AZA-5H-benzo〔A,D〕cyclohepta-5-one
8-CHLORO-5,6-DIHYDRO-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIMIDINE-11-ONE
4-Aza-8-chloro-10,11-dihydro-5H-benzo[a,d]cyclo-5-heptanone
8-CHLORO-10,11-DIHYDRO-4 AZA-5H-BENZO[A,D] CYCLOHEPTAN-5-ONE =98%
8-CHLORO-6,11-DIHYDRO-11-(1-METHYL-4-PIPERIDYLEDENE)-5H-BENZO(5,6)-CYCLOHEPTA(1,2,B)PYRIDINE
8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-β]pyridin-11-one
11H-Benzo[5,6]cyclohepta[1,2-b]pyridin-11-one,8-chloro-5,6-dihydro-
物理化學(xué)性質(zhì)
制備方法
![3-[2-(3-氯苯基)乙基]-2-吡啶甲腈](/CAS/GIF/31255-57-9.gif)
31255-57-9
![8-氯-5,6-二氫-11H-苯并[5,6]環(huán)庚烷并[1,2-b]吡啶-11-酮](/CAS/GIF/31251-41-9.gif)
31251-41-9
以3-(3-氯苯基乙基)吡啶-2-甲腈為原料合成8-氯-5,6-二氫-11H-苯并[5,6]環(huán)庚烷并[1,2-b]吡啶-11-酮的一般步驟:將步驟C中獲得的8-氯-5,6-二氫-11H-苯并[5,6]環(huán)庚烷并[1,2-b]吡啶-11-酮(10g)溶解于三氟磺酸(80ml)中,于60℃下攪拌反應(yīng)1小時(shí)。隨后,在室溫條件下緩慢滴加6N鹽酸水溶液(80ml)。將反應(yīng)混合物回流1小時(shí)后,傾倒入冰水中。用50%氫氧化鈉水溶液中和反應(yīng)液,分離析出的沉淀,用水洗滌,并通過(guò)異丙醇/水(3:1)混合溶劑進(jìn)行重結(jié)晶,得到目標(biāo)產(chǎn)物8-氯-5,6-二氫-11H-苯并[5,6]環(huán)庚烷并[1,2-b]吡啶-11-酮。濃縮母液,殘余物依次用水和氯仿洗滌,可額外獲得8-氯-5,6-二氫-11H-苯并[5,6]環(huán)庚烷并[1,2-b]吡啶-11-酮(9.4g,收率94%)。1H NMR (MeOD-d4) δ: 3.3-3.4 (m, 2H), 3.4-3.5 (m, 2H), 7.5 (m, 2H), 8.1-8.2 (m, 2H), 8.7 (d, 1H), 8.9 (d, 1H)。
參考文獻(xiàn):
[1] Patent: WO2006/116157, 2006, A2. Location in patent: Page/Page column 56-57
[2] Journal of Medicinal Chemistry, 2009, vol. 52, # 6, p. 1778 - 1782
[3] Journal of Medicinal Chemistry, 1991, vol. 34, # 1, p. 457 - 461